Adverum Biotechnologies Stock Market Value
| ADVM Stock | USD 6.45 0.29 4.71% |
| Symbol | Adverum |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Adverum Biotechnologies 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Adverum Biotechnologies' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Adverum Biotechnologies.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Adverum Biotechnologies on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Adverum Biotechnologies or generate 0.0% return on investment in Adverum Biotechnologies over 30 days. Adverum Biotechnologies is related to or competes with Uniqure NV, Rocket Pharmaceuticals, Rhythm Pharmaceuticals, Solid Biosciences, MeiraGTx Holdings, Aerovate Therapeutics, and Adagene. Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ... More
Adverum Biotechnologies Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Adverum Biotechnologies' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Adverum Biotechnologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 16.06 | |||
| Value At Risk | (6.81) | |||
| Potential Upside | 5.04 |
Adverum Biotechnologies Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Adverum Biotechnologies' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Adverum Biotechnologies' standard deviation. In reality, there are many statistical measures that can use Adverum Biotechnologies historical prices to predict the future Adverum Biotechnologies' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.24) | |||
| Total Risk Alpha | (0.60) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adverum Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adverum Biotechnologies Backtested Returns
Adverum Biotechnologies secures Sharpe Ratio (or Efficiency) of -0.0154, which signifies that the company had a -0.0154% return per unit of risk over the last 3 months. Adverum Biotechnologies exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Adverum Biotechnologies' insignificant Risk Adjusted Performance, mean deviation of 2.66, and Standard Deviation of 3.53 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.57, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Adverum Biotechnologies will likely underperform. At this point, Adverum Biotechnologies has a negative expected return of -0.0543%. Please make sure to confirm Adverum Biotechnologies' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Adverum Biotechnologies performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.32 |
Poor reverse predictability
Adverum Biotechnologies has poor reverse predictability. Overlapping area represents the amount of predictability between Adverum Biotechnologies time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Adverum Biotechnologies price movement. The serial correlation of -0.32 indicates that nearly 32.0% of current Adverum Biotechnologies price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.32 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.26 |
Adverum Biotechnologies lagged returns against current returns
Autocorrelation, which is Adverum Biotechnologies stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Adverum Biotechnologies' stock expected returns. We can calculate the autocorrelation of Adverum Biotechnologies returns to help us make a trade decision. For example, suppose you find that Adverum Biotechnologies has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Adverum Biotechnologies regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Adverum Biotechnologies stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Adverum Biotechnologies stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Adverum Biotechnologies stock over time.
Current vs Lagged Prices |
| Timeline |
Adverum Biotechnologies Lagged Returns
When evaluating Adverum Biotechnologies' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Adverum Biotechnologies stock have on its future price. Adverum Biotechnologies autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Adverum Biotechnologies autocorrelation shows the relationship between Adverum Biotechnologies stock current value and its past values and can show if there is a momentum factor associated with investing in Adverum Biotechnologies.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Adverum Biotechnologies Correlation, Adverum Biotechnologies Volatility and Adverum Biotechnologies Alpha and Beta module to complement your research on Adverum Biotechnologies. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Adverum Biotechnologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.